Neratinib safety evaluation: real-world adverse event analysis from the FAERS database
Our study provide new real-world evidence for drug safety information of neratinib. While the majority of our findings were aligned with the information provided in the manual. We identified additional ADEs not previously documented. Consequently, further studies are needed to validate unreported ADEs to ensure the efficacy and safety of neratinib for patients.
Authors
- Xiushan Dong (ORCID: https://orcid.org/0000-0001-7387-7303)
- Haijia Zhang
- Yunhe Fan
- Jie An (ORCID: https://orcid.org/0000-0002-0028-0079)
- Chuanli Yang
- Pengyang Xu
- Mureed Abbas
- Teng Wu
Institutions
- Shanxi Medical University (CN)
- Shanxi University (CN)
- Shanxi Academy of Medical Sciences (CN)
- Southeast University (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2024-09-13
- DOI
- https://doi.org/10.3389/fphar.2024.1425171
- Citations
- 16
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 6.70
Funders
- Natural Science Foundation of Shanxi Province